# Accenture timeline

entity: /record/accenture.md  
id: ent_accenture  


## undated

- undated | listed_on | NYSE | valid | [clm_2142329F1F37](/claim/clm_2142329F1F37.md)
- undated | ticker | ACN | valid | [clm_216B59E04974](/claim/clm_216B59E04974.md)
- undated | state_of_incorporation | L2 | valid | [clm_AA864AAA8942](/claim/clm_AA864AAA8942.md)
- undated | sic_industry | Services-Business Services, NEC (7389) | valid | [clm_CA10D45DF425](/claim/clm_CA10D45DF425.md)
- undated | fiscal_year_end | 08-31 | valid | [clm_DB1470823769](/claim/clm_DB1470823769.md)
- undated | cik | 0001467373 | valid | [clm_F3A94DC12E26](/claim/clm_F3A94DC12E26.md)
- undated | subsidiary | Accenture Federal Services | unverified | [clm_0452A2529DF7](/claim/clm_0452A2529DF7.md)
- undated | member_of | EVOLEN | unverified | [clm_38311D556CD6](/claim/clm_38311D556CD6.md)
- undated | country | Ireland | unverified | [clm_407757D44EFF](/claim/clm_407757D44EFF.md)
- undated | member_of | Deutsche Gesellschaft für Wehrtechnik | unverified | [clm_528FEA15966B](/claim/clm_528FEA15966B.md)
- undated | member_of | JS Foundation | unverified | [clm_76DD10D5AD9F](/claim/clm_76DD10D5AD9F.md)
- undated | website | https://www.accenture.com/ | unverified | [clm_D824BA771A07](/claim/clm_D824BA771A07.md)
- undated | legal_form | Limited Company | unverified | [clm_EED7E581BE99](/claim/clm_EED7E581BE99.md)
- undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_F9CC15A828CB](/claim/clm_F9CC15A828CB.md)
- undated | member_of | German-Swiss Chamber of Commerce | unverified | [clm_FF0840C3DE3C](/claim/clm_FF0840C3DE3C.md)

## 2007

- 2007-08-31 to 2008-08-31 | cash_and_equivalents | 3,314,396,000 United States dollar | superseded | [clm_BB946118C8D1](/claim/clm_BB946118C8D1.md)
- 2007-09-01 to 2008-08-31 | operating_income | 3,011,582,000 United States dollar | superseded | [clm_147478AE8F31](/claim/clm_147478AE8F31.md)
- 2007-09-01 to 2008-08-31 | revenue | 25,313,826,000 United States dollar | superseded | [clm_51A86523AF3B](/claim/clm_51A86523AF3B.md)
- 2007-09-01 to 2008-08-31 | net_income | 1,691,751,000 United States dollar | superseded | [clm_9C90160E50D6](/claim/clm_9C90160E50D6.md)
- 2007-11-12 | x_username | Accenture | unverified | [clm_F2335A2A0984](/claim/clm_F2335A2A0984.md)

## 2008

- 2008-08-31 to 2009-08-31 | research_and_development | 390,168,000 United States dollar | superseded | [clm_43AA341D1E1F](/claim/clm_43AA341D1E1F.md)
- 2008-08-31 to 2008-09-01 | operating_income | 3,011,582,000 United States dollar | superseded | [clm_71D9E47D4A83](/claim/clm_71D9E47D4A83.md)
- 2008-08-31 to 2008-09-01 | net_income | 1,691,751,000 United States dollar | superseded | [clm_95B99D09AA02](/claim/clm_95B99D09AA02.md)
- 2008-08-31 to 2008-11-30 | cash_and_equivalents | 3,602,760,000 United States dollar | superseded | [clm_C8C8F88771FE](/claim/clm_C8C8F88771FE.md)
- 2008-08-31 to 2008-09-01 | revenue | 25,313,826,000 United States dollar | superseded | [clm_D3D908E5E1AD](/claim/clm_D3D908E5E1AD.md)
- 2008-09-01 to 2009-08-31 | net_income | 1,589,963,000 United States dollar | superseded | [clm_A30EE5475EB7](/claim/clm_A30EE5475EB7.md)
- 2008-09-01 to 2009-08-31 | operating_income | 2,643,865,000 United States dollar | superseded | [clm_DDE73C8A5CE5](/claim/clm_DDE73C8A5CE5.md)
- 2008-09-01 to 2009-08-31 | revenue | 23,170,968,000 United States dollar | superseded | [clm_DF35FABA1D53](/claim/clm_DF35FABA1D53.md)
- 2008-11-30 to 2009-02-28 | quarterly_operating_income | 814,772,000 United States dollar | superseded | [clm_2C750A8315BB](/claim/clm_2C750A8315BB.md)
- 2008-11-30 to 2009-02-28 | cash_and_equivalents | 2,782,961,000 United States dollar | superseded | [clm_628540601FB3](/claim/clm_628540601FB3.md)
- 2008-11-30 to 2009-02-28 | quarterly_net_income | 479,866,000 United States dollar | superseded | [clm_80410000D27C](/claim/clm_80410000D27C.md)
- 2008-11-30 to 2009-02-28 | quarterly_revenue | 6,470,608,000 United States dollar | superseded | [clm_F0CA89CDBC0D](/claim/clm_F0CA89CDBC0D.md)

## 2009

- 2009-02-28 to 2009-05-31 | quarterly_operating_income | 677,467,000 United States dollar | superseded | [clm_2F25E5AC27DE](/claim/clm_2F25E5AC27DE.md)
- 2009-02-28 to 2009-05-31 | cash_and_equivalents | 2,978,000,000 United States dollar | superseded | [clm_3ECBF965FC6A](/claim/clm_3ECBF965FC6A.md)
- 2009-02-28 to 2009-05-31 | quarterly_revenue | 5,657,563,000 United States dollar | superseded | [clm_5269D941D43C](/claim/clm_5269D941D43C.md)
- 2009-02-28 to 2009-05-31 | quarterly_net_income | 411,436,000 United States dollar | superseded | [clm_997986363ED5](/claim/clm_997986363ED5.md)
- 2009-05-31 to 2009-11-30 | quarterly_operating_income | 732,040,000 United States dollar | superseded | [clm_024B8083E6E2](/claim/clm_024B8083E6E2.md)
- 2009-05-31 to 2009-11-30 | quarterly_revenue | 5,537,348,000 United States dollar | superseded | [clm_26FA4CE4A7E4](/claim/clm_26FA4CE4A7E4.md)
- 2009-05-31 to 2009-11-30 | quarterly_net_income | 443,969,000 United States dollar | superseded | [clm_34F76A5875F0](/claim/clm_34F76A5875F0.md)
- 2009-05-31 to 2009-08-31 | cash_and_equivalents | 4,002,459,000 United States dollar | superseded | [clm_9E8DB73D9F62](/claim/clm_9E8DB73D9F62.md)
- 2009-08-31 to 2009-11-30 | cash_and_equivalents | 4,541,662,000 United States dollar | superseded | [clm_07A8DD021245](/claim/clm_07A8DD021245.md)
- 2009-08-31 to 2009-09-01 | operating_income | 2,643,865,000 United States dollar | superseded | [clm_44C7FA58DC1A](/claim/clm_44C7FA58DC1A.md)
- 2009-08-31 to 2009-11-30 | total_equity | 2,835,221,000 United States dollar | superseded | [clm_AC3BEA3F7DA3](/claim/clm_AC3BEA3F7DA3.md)
- 2009-08-31 to 2009-09-01 | revenue | 23,170,968,000 United States dollar | superseded | [clm_B8EE6FF7CA39](/claim/clm_B8EE6FF7CA39.md)
- 2009-08-31 to 2009-09-01 | net_income | 1,589,963,000 United States dollar | superseded | [clm_E4AF072351CF](/claim/clm_E4AF072351CF.md)
- 2009-08-31 to 2010-08-31 | research_and_development | 434,937,000 United States dollar | superseded | [clm_F86190A96847](/claim/clm_F86190A96847.md)
- 2009-08-31 to 2009-11-30 | total_assets | 12,255,734,000 United States dollar | superseded | [clm_FD6F2EF29259](/claim/clm_FD6F2EF29259.md)
- 2009-09-01 to 2010-08-31 | net_income | 1,780,656,000 United States dollar | superseded | [clm_8B08E813CB89](/claim/clm_8B08E813CB89.md)
- 2009-09-01 to 2010-08-31 | operating_income | 2,914,845,000 United States dollar | superseded | [clm_94BCF7A687F4](/claim/clm_94BCF7A687F4.md)
- 2009-09-01 | registrant_name | Accenture plc | valid | [clm_A1E32C955DFB](/claim/clm_A1E32C955DFB.md)
- 2009-11-30 to 2010-02-28 | quarterly_net_income | 444,817,000 United States dollar | superseded | [clm_27D0B872FB5A](/claim/clm_27D0B872FB5A.md)
- 2009-11-30 to 2010-02-28 | quarterly_operating_income | 746,408,000 United States dollar | superseded | [clm_422A6773B196](/claim/clm_422A6773B196.md)
- 2009-11-30 to 2010-02-28 | total_equity | 2,809,267,000 United States dollar | superseded | [clm_8F6066AF1FB9](/claim/clm_8F6066AF1FB9.md)
- 2009-11-30 to 2010-02-28 | total_assets | 12,184,819,000 United States dollar | superseded | [clm_921D4C417082](/claim/clm_921D4C417082.md)
- 2009-11-30 to 2010-02-28 | quarterly_revenue | 5,747,687,000 United States dollar | superseded | [clm_C9BC82FDA7FC](/claim/clm_C9BC82FDA7FC.md)
- 2009-11-30 to 2010-02-28 | cash_and_equivalents | 4,000,063,000 United States dollar | superseded | [clm_F467751008B2](/claim/clm_F467751008B2.md)
- 2009-12-14 to 2010-03-19 | shares_outstanding | 632,423,581 shares | superseded | [clm_979CEE4A9CF3](/claim/clm_979CEE4A9CF3.md)

## 2010

- 2010-02-28 to 2010-05-31 | total_assets | 11,890,088,000 United States dollar | superseded | [clm_076065DF7ECE](/claim/clm_076065DF7ECE.md)
- 2010-02-28 to 2010-05-31 | quarterly_net_income | 399,760,000 United States dollar | superseded | [clm_8627A4B26032](/claim/clm_8627A4B26032.md)
- 2010-02-28 to 2010-05-31 | quarterly_revenue | 5,537,823,000 United States dollar | superseded | [clm_8722A6ABE392](/claim/clm_8722A6ABE392.md)
- 2010-02-28 to 2010-05-31 | total_equity | 2,959,496,000 United States dollar | superseded | [clm_B47871FF2D39](/claim/clm_B47871FF2D39.md)
- 2010-02-28 to 2010-05-31 | cash_and_equivalents | 4,114,751,000 United States dollar | superseded | [clm_D8A97F8192AC](/claim/clm_D8A97F8192AC.md)
- 2010-02-28 to 2010-05-31 | quarterly_operating_income | 650,973,000 United States dollar | superseded | [clm_E45FE8BF45EB](/claim/clm_E45FE8BF45EB.md)
- 2010-03-19 | shares_outstanding | 637,016,143 shares | valid | [clm_A51D7432533C](/claim/clm_A51D7432533C.md)
- 2010-05-31 to 2010-11-30 | quarterly_operating_income | 803,830,000 United States dollar | superseded | [clm_58761533CB94](/claim/clm_58761533CB94.md)
- 2010-05-31 to 2010-08-31 | total_equity | 2,996,630,000 United States dollar | superseded | [clm_7760EF370B1B](/claim/clm_7760EF370B1B.md)
- 2010-05-31 to 2010-08-31 | cash_and_equivalents | 4,312,111,000 United States dollar | superseded | [clm_9E5124EFA3A3](/claim/clm_9E5124EFA3A3.md)
- 2010-05-31 to 2010-11-30 | quarterly_net_income | 490,597,000 United States dollar | superseded | [clm_B1CC8CA461F9](/claim/clm_B1CC8CA461F9.md)
- 2010-05-31 to 2010-08-31 | total_assets | 11,917,658,000 United States dollar | superseded | [clm_B5BEB84ABCF1](/claim/clm_B5BEB84ABCF1.md)
- 2010-05-31 to 2010-11-30 | quarterly_revenue | 5,975,495,000 United States dollar | superseded | [clm_CE21561D537D](/claim/clm_CE21561D537D.md)
- 2010-08-31 to 2010-09-01 | net_income | 1,780,656,000 United States dollar | superseded | [clm_516682C84717](/claim/clm_516682C84717.md)
- 2010-08-31 to 2010-09-01 | revenue | 23,094,078,000 United States dollar | superseded | [clm_5CB16F92C4CB](/claim/clm_5CB16F92C4CB.md)
- 2010-08-31 to 2010-11-30 | total_assets | 12,835,253,000 United States dollar | superseded | [clm_6B62DCE05BA3](/claim/clm_6B62DCE05BA3.md)
- 2010-08-31 to 2010-11-30 | total_equity | 2,835,746,000 United States dollar | superseded | [clm_72997A595426](/claim/clm_72997A595426.md)
- 2010-08-31 to 2010-09-01 | operating_income | 2,914,845,000 United States dollar | superseded | [clm_BBBC399A6273](/claim/clm_BBBC399A6273.md)
- 2010-08-31 to 2010-11-30 | cash_and_equivalents | 4,838,292,000 United States dollar | superseded | [clm_D620AF360CA6](/claim/clm_D620AF360CA6.md)
- 2010-08-31 to 2011-08-31 | research_and_development | 383,700,000 United States dollar | superseded | [clm_D8002FA1402F](/claim/clm_D8002FA1402F.md)
- 2010-09-01 to 2011-08-31 | operating_income | 3,470,457,000 United States dollar | superseded | [clm_2EDE0B966F16](/claim/clm_2EDE0B966F16.md)
- 2010-09-01 to 2011-08-31 | net_income | 2,277,677,000 United States dollar | superseded | [clm_8CDDBEC2A853](/claim/clm_8CDDBEC2A853.md)
- 2010-09-01 to 2011-08-31 | revenue | 27,352,914,000 United States dollar | superseded | [clm_ACF560458814](/claim/clm_ACF560458814.md)
- 2010-11-30 to 2011-02-28 | total_equity | 2,909,396,000 United States dollar | superseded | [clm_4CF98285BF82](/claim/clm_4CF98285BF82.md)
- 2010-11-30 to 2011-02-28 | total_assets | 12,868,874,000 United States dollar | superseded | [clm_6143953E50AB](/claim/clm_6143953E50AB.md)
- 2010-11-30 to 2011-02-28 | cash_and_equivalents | 4,160,452,000 United States dollar | superseded | [clm_7CAB3E80DE4A](/claim/clm_7CAB3E80DE4A.md)
- 2010-11-30 to 2011-02-28 | quarterly_revenue | 6,478,193,000 United States dollar | superseded | [clm_9198A44E55E0](/claim/clm_9198A44E55E0.md)
- 2010-11-30 to 2011-02-28 | quarterly_net_income | 534,714,000 United States dollar | superseded | [clm_D2880713E3D2](/claim/clm_D2880713E3D2.md)
- 2010-11-30 to 2011-02-28 | quarterly_operating_income | 826,935,000 United States dollar | superseded | [clm_E8C97FA7007E](/claim/clm_E8C97FA7007E.md)

## 2011

- 2011-02-28 to 2011-05-31 | quarterly_net_income | 503,017,000 United States dollar | superseded | [clm_14FC543473B5](/claim/clm_14FC543473B5.md)
- 2011-02-28 to 2011-05-31 | quarterly_operating_income | 771,577,000 United States dollar | superseded | [clm_36F96961C8CB](/claim/clm_36F96961C8CB.md)
- 2011-02-28 to 2011-05-31 | cash_and_equivalents | 4,677,544,000 United States dollar | superseded | [clm_50065605711B](/claim/clm_50065605711B.md)
- 2011-02-28 to 2011-05-31 | total_equity | 3,592,907,000 United States dollar | superseded | [clm_9057729A878A](/claim/clm_9057729A878A.md)
- 2011-02-28 to 2011-05-31 | total_assets | 13,893,673,000 United States dollar | superseded | [clm_C4FEA65BDFF3](/claim/clm_C4FEA65BDFF3.md)
- 2011-02-28 to 2011-05-31 | quarterly_revenue | 6,496,293,000 United States dollar | superseded | [clm_EC7078315A67](/claim/clm_EC7078315A67.md)
- 2011-05-31 to 2011-11-30 | quarterly_revenue | 7,204,355,000 United States dollar | superseded | [clm_0B251553AE4B](/claim/clm_0B251553AE4B.md)
- 2011-05-31 to 2011-08-31 | total_assets | 14,903,969,000 United States dollar | superseded | [clm_186FF1521CC9](/claim/clm_186FF1521CC9.md)
- 2011-05-31 to 2011-11-30 | quarterly_net_income | 628,013,000 United States dollar | superseded | [clm_409E45CBC4AF](/claim/clm_409E45CBC4AF.md)
- 2011-05-31 to 2011-11-30 | quarterly_operating_income | 949,416,000 United States dollar | superseded | [clm_549A4003F729](/claim/clm_549A4003F729.md)
- 2011-05-31 to 2011-08-31 | cash_and_equivalents | 5,256,684,000 United States dollar | superseded | [clm_AE679A330B48](/claim/clm_AE679A330B48.md)
- 2011-05-31 to 2011-08-31 | total_equity | 3,713,803,000 United States dollar | superseded | [clm_F5E2F631567F](/claim/clm_F5E2F631567F.md)
- 2011-08-31 to 2011-11-30 | cash_and_equivalents | 5,701,078,000 United States dollar | superseded | [clm_0C47B8EAD07F](/claim/clm_0C47B8EAD07F.md)
- 2011-08-31 to 2012-08-31 | research_and_development | 503,222,000 United States dollar | superseded | [clm_2D6DE80297FB](/claim/clm_2D6DE80297FB.md)
- 2011-08-31 to 2011-09-01 | net_income | 2,277,677,000 United States dollar | superseded | [clm_44A5B9CE70DD](/claim/clm_44A5B9CE70DD.md)
- 2011-08-31 to 2011-11-30 | total_assets | 15,731,510,000 United States dollar | superseded | [clm_5960896B0791](/claim/clm_5960896B0791.md)
- 2011-08-31 to 2011-09-01 | operating_income | 3,470,457,000 United States dollar | superseded | [clm_849E56BD8579](/claim/clm_849E56BD8579.md)
- 2011-08-31 to 2011-09-01 | revenue | 27,352,914,000 United States dollar | superseded | [clm_C242B1F6A19E](/claim/clm_C242B1F6A19E.md)
- 2011-08-31 to 2011-11-30 | total_equity | 3,878,951,000 United States dollar | superseded | [clm_DAFFD2207DE5](/claim/clm_DAFFD2207DE5.md)
- 2011-09-01 to 2012-08-31 | operating_income | 3,871,548,000 United States dollar | superseded | [clm_ADEE12AB5C43](/claim/clm_ADEE12AB5C43.md)
- 2011-09-01 to 2012-08-31 | net_income | 2,553,510,000 United States dollar | superseded | [clm_E2507A7FC9DA](/claim/clm_E2507A7FC9DA.md)
- 2011-09-01 to 2012-08-31 | revenue | 29,777,985,000 United States dollar | superseded | [clm_E6506AC2A8E7](/claim/clm_E6506AC2A8E7.md)
- 2011-11-30 to 2012-02-29 | cash_and_equivalents | 5,091,906,000 United States dollar | superseded | [clm_1864614DC9D8](/claim/clm_1864614DC9D8.md)
- 2011-11-30 to 2012-02-29 | quarterly_net_income | 642,086,000 United States dollar | superseded | [clm_34520F02D4FE](/claim/clm_34520F02D4FE.md)
- 2011-11-30 to 2012-02-29 | quarterly_revenue | 7,589,108,000 United States dollar | superseded | [clm_388C67068B2D](/claim/clm_388C67068B2D.md)
- 2011-11-30 to 2012-02-29 | total_equity | 3,766,360,000 United States dollar | superseded | [clm_45BEDD5A54AD](/claim/clm_45BEDD5A54AD.md)
- 2011-11-30 to 2012-02-29 | quarterly_operating_income | 981,138,000 United States dollar | superseded | [clm_9E4FA452AD33](/claim/clm_9E4FA452AD33.md)
- 2011-11-30 to 2012-02-29 | total_assets | 15,290,845,000 United States dollar | superseded | [clm_AE142A3F1CEB](/claim/clm_AE142A3F1CEB.md)

## 2012

- 2012-02-29 to 2012-05-31 | quarterly_operating_income | 889,299,000 United States dollar | superseded | [clm_1BBBF652220C](/claim/clm_1BBBF652220C.md)
- 2012-02-29 to 2012-05-31 | cash_and_equivalents | 5,568,746,000 United States dollar | superseded | [clm_4A37EE47D04B](/claim/clm_4A37EE47D04B.md)
- 2012-02-29 to 2012-05-31 | total_equity | 4,468,553,000 United States dollar | superseded | [clm_661E210486CC](/claim/clm_661E210486CC.md)
- 2012-02-29 to 2012-05-31 | quarterly_net_income | 643,923,000 United States dollar | superseded | [clm_6D98DC847C2D](/claim/clm_6D98DC847C2D.md)
- 2012-02-29 to 2012-05-31 | total_assets | 15,808,096,000 United States dollar | superseded | [clm_A7DE5202BACE](/claim/clm_A7DE5202BACE.md)
- 2012-02-29 to 2012-05-31 | quarterly_revenue | 7,259,828,000 United States dollar | superseded | [clm_F093E9F32C70](/claim/clm_F093E9F32C70.md)
- 2012-04-27 | board_member | Gilles Pélisson | valid | [clm_27CDE4FB9A71](/claim/clm_27CDE4FB9A71.md)
- 2012-05-31 to 2012-08-31 | total_equity | 4,106,004,000 United States dollar | superseded | [clm_09E5DD18545A](/claim/clm_09E5DD18545A.md)
- 2012-05-31 to 2012-11-30 | quarterly_revenue | 7,640,790,000 United States dollar | superseded | [clm_0C9907D9E190](/claim/clm_0C9907D9E190.md)
- 2012-05-31 to 2012-08-31 | total_assets | 15,535,915,000 United States dollar | superseded | [clm_49C160036885](/claim/clm_49C160036885.md)
- 2012-05-31 to 2012-11-30 | quarterly_operating_income | 1,060,761,000 United States dollar | superseded | [clm_6B9217844CFF](/claim/clm_6B9217844CFF.md)
- 2012-05-31 to 2012-11-30 | quarterly_net_income | 689,219,000 United States dollar | superseded | [clm_C163961C47F8](/claim/clm_C163961C47F8.md)
- 2012-05-31 to 2012-08-31 | cash_and_equivalents | 5,628,659,000 United States dollar | superseded | [clm_C1EBCF91AFF5](/claim/clm_C1EBCF91AFF5.md)
- 2012-08-31 to 2012-09-01 | operating_income | 3,871,548,000 United States dollar | superseded | [clm_2BA6755188B3](/claim/clm_2BA6755188B3.md)
- 2012-08-31 to 2012-11-30 | cash_and_equivalents | 6,640,526,000 United States dollar | superseded | [clm_5ADEC78408A2](/claim/clm_5ADEC78408A2.md)
- 2012-08-31 to 2012-11-30 | total_equity | 4,145,833,000 United States dollar | superseded | [clm_71AA72576A68](/claim/clm_71AA72576A68.md)
- 2012-08-31 to 2012-09-01 | revenue | 29,777,985,000 United States dollar | superseded | [clm_7D803852B80B](/claim/clm_7D803852B80B.md)
- 2012-08-31 to 2012-11-30 | total_assets | 16,665,415,000 United States dollar | superseded | [clm_908A457ADF03](/claim/clm_908A457ADF03.md)
- 2012-08-31 to 2013-08-31 | research_and_development | 559,611,000 United States dollar | superseded | [clm_BA669D4F6AB8](/claim/clm_BA669D4F6AB8.md)
- 2012-08-31 to 2012-09-01 | net_income | 2,553,510,000 United States dollar | superseded | [clm_BE5CA2C26F94](/claim/clm_BE5CA2C26F94.md)
- 2012-09-01 to 2013-08-31 | net_income | 3,281,878,000 United States dollar | superseded | [clm_C28E6818AD94](/claim/clm_C28E6818AD94.md)
- 2012-09-01 to 2013-08-31 | revenue | 30,394,285,000 United States dollar | superseded | [clm_E42052023278](/claim/clm_E42052023278.md)
- 2012-09-01 to 2013-08-31 | operating_income | 4,338,680,000 United States dollar | superseded | [clm_FD6BCD7EF96C](/claim/clm_FD6BCD7EF96C.md)
- 2012-11-30 to 2013-02-28 | quarterly_net_income | 698,817,000 United States dollar | superseded | [clm_16EDCAB69BE1](/claim/clm_16EDCAB69BE1.md)
- 2012-11-30 to 2013-02-28 | cash_and_equivalents | 5,678,892,000 United States dollar | superseded | [clm_19E4C77631EE](/claim/clm_19E4C77631EE.md)
- 2012-11-30 to 2013-02-28 | total_assets | 16,408,020,000 United States dollar | superseded | [clm_384400BB1612](/claim/clm_384400BB1612.md)
- 2012-11-30 to 2013-02-28 | quarterly_operating_income | 1,048,674,000 United States dollar | superseded | [clm_8AD622B8ACA6](/claim/clm_8AD622B8ACA6.md)
- 2012-11-30 to 2013-02-28 | total_equity | 4,506,633,000 United States dollar | superseded | [clm_91EE4762C7D7](/claim/clm_91EE4762C7D7.md)
- 2012-11-30 to 2013-02-28 | quarterly_revenue | 7,668,036,000 United States dollar | superseded | [clm_A579EA5E7E0F](/claim/clm_A579EA5E7E0F.md)

## 2013

- 2013-02-28 to 2013-05-31 | total_equity | 5,452,349,000 United States dollar | superseded | [clm_862FA87A8009](/claim/clm_862FA87A8009.md)
- 2013-02-28 to 2013-05-31 | total_assets | 16,358,730,000 United States dollar | superseded | [clm_A508F5A10372](/claim/clm_A508F5A10372.md)
- 2013-02-28 to 2013-05-31 | quarterly_revenue | 7,493,320,000 United States dollar | superseded | [clm_BB0285802EDE](/claim/clm_BB0285802EDE.md)
- 2013-02-28 to 2013-05-31 | quarterly_operating_income | 1,164,532,000 United States dollar | superseded | [clm_BF0FE2BDE84C](/claim/clm_BF0FE2BDE84C.md)
- 2013-02-28 to 2013-05-31 | cash_and_equivalents | 5,636,086,000 United States dollar | superseded | [clm_D12E12FCDBEF](/claim/clm_D12E12FCDBEF.md)
- 2013-02-28 to 2013-05-31 | quarterly_net_income | 1,101,802,000 United States dollar | superseded | [clm_FFDCD136D9D7](/claim/clm_FFDCD136D9D7.md)
- 2013-05-31 to 2013-11-30 | quarterly_net_income | 810,258,000 United States dollar | superseded | [clm_1B86B25A607F](/claim/clm_1B86B25A607F.md)
- 2013-05-31 to 2013-11-30 | quarterly_revenue | 7,707,935,000 United States dollar | superseded | [clm_34804C5F368C](/claim/clm_34804C5F368C.md)
- 2013-05-31 to 2013-08-31 | total_equity | 5,324,867,000 United States dollar | superseded | [clm_5AE1823F41C6](/claim/clm_5AE1823F41C6.md)
- 2013-05-31 to 2013-08-31 | total_assets | 16,523,758,000 United States dollar | superseded | [clm_8D4A69C9A3A0](/claim/clm_8D4A69C9A3A0.md)
- 2013-05-31 to 2013-08-31 | cash_and_equivalents | 5,938,085,000 United States dollar | superseded | [clm_9CD416F1F3D3](/claim/clm_9CD416F1F3D3.md)
- 2013-05-31 to 2013-11-30 | quarterly_operating_income | 1,141,971,000 United States dollar | superseded | [clm_CD87D7DB4F4B](/claim/clm_CD87D7DB4F4B.md)
- 2013-08-20 | board_member | Jaime Ardila | valid | [clm_5FCF120F7D5B](/claim/clm_5FCF120F7D5B.md)
- 2013-08-31 to 2013-11-30 | cash_and_equivalents | 5,631,885,000 United States dollar | superseded | [clm_0A58313A2969](/claim/clm_0A58313A2969.md)
- 2013-08-31 to 2013-11-30 | total_equity | 4,960,186,000 United States dollar | superseded | [clm_266846A8CF31](/claim/clm_266846A8CF31.md)
- 2013-08-31 to 2013-11-30 | total_assets | 16,867,049,000 United States dollar | superseded | [clm_294D3A0BB5FE](/claim/clm_294D3A0BB5FE.md)
- 2013-08-31 to 2013-09-01 | operating_income | 4,338,680,000 United States dollar | superseded | [clm_53BC000E0EBC](/claim/clm_53BC000E0EBC.md)
- 2013-08-31 to 2014-08-31 | research_and_development | 715,094,000 United States dollar | superseded | [clm_A19904EB9BE8](/claim/clm_A19904EB9BE8.md)
- 2013-08-31 to 2013-09-01 | revenue | 30,394,285,000 United States dollar | superseded | [clm_C13C1F09C95F](/claim/clm_C13C1F09C95F.md)
- 2013-08-31 to 2014-08-31 | net_income | 3,281,878,000 United States dollar | superseded | [clm_D8EEB218C3F1](/claim/clm_D8EEB218C3F1.md)
- 2013-09-01 to 2014-08-31 | revenue | 31,874,678,000 United States dollar | superseded | [clm_083C4E8C05B4](/claim/clm_083C4E8C05B4.md)
- 2013-11-30 to 2014-02-28 | cash_and_equivalents | 4,527,198,000 United States dollar | superseded | [clm_07B94ECE07A2](/claim/clm_07B94ECE07A2.md)
- 2013-11-30 to 2014-02-28 | quarterly_operating_income | 1,091,099,000 United States dollar | superseded | [clm_2856D71C4C07](/claim/clm_2856D71C4C07.md)
- 2013-11-30 to 2014-02-28 | quarterly_net_income | 751,846,000 United States dollar | superseded | [clm_3E6D0301CDE6](/claim/clm_3E6D0301CDE6.md)
- 2013-11-30 to 2014-02-28 | total_assets | 16,515,938,000 United States dollar | superseded | [clm_6B59D7264132](/claim/clm_6B59D7264132.md)
- 2013-11-30 to 2014-02-28 | total_equity | 4,927,831,000 United States dollar | superseded | [clm_B450998F8D86](/claim/clm_B450998F8D86.md)
- 2013-11-30 to 2014-02-28 | quarterly_revenue | 7,799,696,000 United States dollar | superseded | [clm_DF35D96540DF](/claim/clm_DF35D96540DF.md)

## 2014

- 2014-02-28 to 2014-05-31 | total_equity | 5,272,315,000 United States dollar | superseded | [clm_65ABF0BE2B6B](/claim/clm_65ABF0BE2B6B.md)
- 2014-02-28 to 2014-05-31 | cash_and_equivalents | 3,680,274,000 United States dollar | superseded | [clm_7F7DDC3D8835](/claim/clm_7F7DDC3D8835.md)
- 2014-02-28 to 2014-05-31 | total_assets | 16,357,209,000 United States dollar | superseded | [clm_9E5CDF3C0185](/claim/clm_9E5CDF3C0185.md)
- 2014-02-28 to 2014-05-31 | quarterly_net_income | 671,300,000 United States dollar | superseded | [clm_AACE8CA86E6E](/claim/clm_AACE8CA86E6E.md)
- 2014-02-28 to 2014-05-31 | quarterly_operating_income | 951,282,000 United States dollar | superseded | [clm_D71F416F8FF7](/claim/clm_D71F416F8FF7.md)
- 2014-02-28 to 2014-05-31 | quarterly_revenue | 7,567,483,000 United States dollar | superseded | [clm_E6B2CB6E716C](/claim/clm_E6B2CB6E716C.md)
- 2014-05-09 | board_member | Paula Price | valid | [clm_5C486835F0D8](/claim/clm_5C486835F0D8.md)
- 2014-05-31 to 2014-11-30 | quarterly_net_income | 817,336,000 United States dollar | superseded | [clm_5B110ADA1EC2](/claim/clm_5B110ADA1EC2.md)
- 2014-05-31 to 2014-08-31 | cash_and_equivalents | 4,048,859,000 United States dollar | superseded | [clm_695414C6D1BB](/claim/clm_695414C6D1BB.md)
- 2014-05-31 to 2014-11-30 | quarterly_operating_income | 1,178,766,000 United States dollar | superseded | [clm_7894667310E2](/claim/clm_7894667310E2.md)
- 2014-05-31 to 2014-11-30 | quarterly_revenue | 8,240,180,000 United States dollar | superseded | [clm_88BB4A104C72](/claim/clm_88BB4A104C72.md)
- 2014-05-31 to 2014-08-31 | total_equity | 5,603,631,000 United States dollar | superseded | [clm_9D48B1601F10](/claim/clm_9D48B1601F10.md)
- 2014-05-31 to 2014-08-31 | total_assets | 17,002,384,000 United States dollar | superseded | [clm_EBFE6848BE20](/claim/clm_EBFE6848BE20.md)
- 2014-08-31 to 2014-11-30 | cash_and_equivalents | 4,921,305,000 United States dollar | superseded | [clm_050AA380FE4C](/claim/clm_050AA380FE4C.md)
- 2014-08-31 to 2014-09-01 | operating_income | 4,300,512,000 United States dollar | superseded | [clm_4FF737FA43B1](/claim/clm_4FF737FA43B1.md)
- 2014-08-31 to 2014-09-01 | revenue | 31,874,678,000 United States dollar | superseded | [clm_570C9E7A2761](/claim/clm_570C9E7A2761.md)
- 2014-08-31 to 2014-09-01 | net_income | 2,941,498,000 United States dollar | superseded | [clm_8906DB4D5719](/claim/clm_8906DB4D5719.md)
- 2014-08-31 to 2014-11-30 | total_equity | 5,732,035,000 United States dollar | superseded | [clm_8FC302017939](/claim/clm_8FC302017939.md)
- 2014-08-31 to 2014-11-30 | total_assets | 17,930,452,000 United States dollar | superseded | [clm_B4807F7DFD4B](/claim/clm_B4807F7DFD4B.md)
- 2014-08-31 to 2015-08-31 | research_and_development | 639,513,000 United States dollar | superseded | [clm_EED50F6BA633](/claim/clm_EED50F6BA633.md)
- 2014-09-01 to 2015-08-31 | operating_income | 4,435,869,000 United States dollar | superseded | [clm_38A6FCEED9EF](/claim/clm_38A6FCEED9EF.md)
- 2014-09-01 to 2015-08-31 | revenue | 32,914,424,000 United States dollar | superseded | [clm_4B1AA0ECB776](/claim/clm_4B1AA0ECB776.md)
- 2014-09-01 to 2014-12-31 | net_income | 3,053,581,000 United States dollar | superseded | [clm_9D43CAACB04D](/claim/clm_9D43CAACB04D.md)
- 2014-11-30 to 2015-02-28 | quarterly_net_income | 831,530,000 United States dollar | superseded | [clm_6FB3F4611BC6](/claim/clm_6FB3F4611BC6.md)
- 2014-11-30 to 2015-02-28 | cash_and_equivalents | 4,472,347,000 United States dollar | superseded | [clm_9F163A5705EB](/claim/clm_9F163A5705EB.md)
- 2014-11-30 to 2015-02-28 | total_assets | 17,630,033,000 United States dollar | superseded | [clm_AA16D95AAD9E](/claim/clm_AA16D95AAD9E.md)
- 2014-11-30 to 2015-02-28 | quarterly_revenue | 8,343,257,000 United States dollar | superseded | [clm_D1AAFB4D6000](/claim/clm_D1AAFB4D6000.md)
- 2014-11-30 to 2015-02-28 | total_equity | 5,481,501,000 United States dollar | superseded | [clm_D55995C3B634](/claim/clm_D55995C3B634.md)
- 2014-11-30 to 2015-02-28 | quarterly_operating_income | 1,187,709,000 United States dollar | superseded | [clm_FA2A57173220](/claim/clm_FA2A57173220.md)
- 2014-12-31 to 2015-08-31 | net_income | 2,941,498,000 United States dollar | superseded | [clm_4657EA7957F8](/claim/clm_4657EA7957F8.md)

## 2015

- 2015-02-28 to 2015-05-31 | quarterly_revenue | 7,931,590,000 United States dollar | superseded | [clm_37E3B4BCAF75](/claim/clm_37E3B4BCAF75.md)
- 2015-02-28 to 2015-05-31 | total_equity | 5,990,851,000 United States dollar | superseded | [clm_7F7C74F27A2E](/claim/clm_7F7C74F27A2E.md)
- 2015-02-28 to 2015-05-31 | quarterly_operating_income | 1,021,033,000 United States dollar | superseded | [clm_8C20514BDB0D](/claim/clm_8C20514BDB0D.md)
- 2015-02-28 to 2015-05-31 | total_assets | 16,991,565,000 United States dollar | superseded | [clm_A98609243CB4](/claim/clm_A98609243CB4.md)
- 2015-02-28 to 2015-05-31 | cash_and_equivalents | 4,061,400,000 United States dollar | superseded | [clm_C75D8B22C052](/claim/clm_C75D8B22C052.md)
- 2015-02-28 to 2015-05-31 | quarterly_net_income | 690,726,000 United States dollar | superseded | [clm_DC7C5E70BA36](/claim/clm_DC7C5E70BA36.md)
- 2015-05-31 to 2015-11-30 | quarterly_revenue | 8,275,066,000 United States dollar | superseded | [clm_35A89F390926](/claim/clm_35A89F390926.md)
- 2015-05-31 to 2015-11-30 | quarterly_net_income | 793,697,000 United States dollar | superseded | [clm_35DB31E4DFC6](/claim/clm_35DB31E4DFC6.md)
- 2015-05-31 to 2015-08-31 | total_assets | 17,308,727,000 United States dollar | superseded | [clm_4A970F1D8664](/claim/clm_4A970F1D8664.md)
- 2015-05-31 to 2015-11-30 | quarterly_operating_income | 1,133,519,000 United States dollar | superseded | [clm_67C0E0E6D5C0](/claim/clm_67C0E0E6D5C0.md)
- 2015-05-31 to 2015-08-31 | cash_and_equivalents | 4,026,189,000 United States dollar | superseded | [clm_80F554A002D9](/claim/clm_80F554A002D9.md)
- 2015-05-31 to 2015-08-31 | total_equity | 5,911,214,000 United States dollar | superseded | [clm_DB13AF643ABE](/claim/clm_DB13AF643ABE.md)
- 2015-08-31 to 2015-11-30 | cash_and_equivalents | 4,360,766,000 United States dollar | superseded | [clm_105E602E7A86](/claim/clm_105E602E7A86.md)
- 2015-08-31 to 2015-09-01 | operating_income | 4,435,869,000 United States dollar | superseded | [clm_3698951EFDE2](/claim/clm_3698951EFDE2.md)
- 2015-08-31 to 2015-09-01 | net_income | 3,053,581,000 United States dollar | superseded | [clm_37005EDCE12F](/claim/clm_37005EDCE12F.md)
- 2015-08-31 to 2016-08-31 | research_and_development | 625,541,000 United States dollar | superseded | [clm_3F3D010D1DD2](/claim/clm_3F3D010D1DD2.md)
- 2015-08-31 to 2015-11-30 | total_assets | 18,266,058,000 United States dollar | superseded | [clm_C12E01F20878](/claim/clm_C12E01F20878.md)
- 2015-08-31 to 2015-09-01 | revenue | 32,914,424,000 United States dollar | superseded | [clm_D5F7F56F1333](/claim/clm_D5F7F56F1333.md)
- 2015-08-31 to 2015-11-30 | total_equity | 6,133,725,000 United States dollar | superseded | [clm_E43154F80873](/claim/clm_E43154F80873.md)
- 2015-09-01 to 2016-08-31 | operating_income | 4,810,445,000 United States dollar | superseded | [clm_144E5C4177C0](/claim/clm_144E5C4177C0.md)
- 2015-09-01 to 2016-08-31 | revenue | 34,797,661,000 United States dollar | superseded | [clm_B51BACAC45DE](/claim/clm_B51BACAC45DE.md)
- 2015-09-01 to 2016-08-31 | net_income | 4,111,892,000 United States dollar | superseded | [clm_DE7A69AE4813](/claim/clm_DE7A69AE4813.md)
- 2015-10-30 | board_member | Arun Sarin | valid | [clm_A679A4C1C6A0](/claim/clm_A679A4C1C6A0.md)
- 2015-11-30 to 2016-02-29 | quarterly_operating_income | 1,221,260,000 United States dollar | superseded | [clm_0734DA1C9489](/claim/clm_0734DA1C9489.md)
- 2015-11-30 to 2016-02-29 | quarterly_revenue | 8,465,984,000 United States dollar | superseded | [clm_36C06F573E9B](/claim/clm_36C06F573E9B.md)
- 2015-11-30 to 2016-02-29 | cash_and_equivalents | 3,073,193,000 United States dollar | superseded | [clm_50F8E9BA8651](/claim/clm_50F8E9BA8651.md)
- 2015-11-30 to 2016-02-29 | quarterly_net_income | 818,899,000 United States dollar | superseded | [clm_69EED5AC6BF1](/claim/clm_69EED5AC6BF1.md)
- 2015-11-30 to 2016-02-29 | total_assets | 17,993,875,000 United States dollar | superseded | [clm_72CBA921C388](/claim/clm_72CBA921C388.md)
- 2015-11-30 to 2016-02-29 | total_equity | 5,900,425,000 United States dollar | superseded | [clm_F24F50CE6CED](/claim/clm_F24F50CE6CED.md)

## 2016

- 2016-02-29 to 2016-05-31 | quarterly_revenue | 8,397,053,000 United States dollar | superseded | [clm_2C464E02613F](/claim/clm_2C464E02613F.md)
- 2016-02-29 to 2016-05-31 | cash_and_equivalents | 3,034,659,000 United States dollar | superseded | [clm_3AA4E5F1508F](/claim/clm_3AA4E5F1508F.md)
- 2016-02-29 to 2016-05-31 | total_assets | 18,147,778,000 United States dollar | superseded | [clm_42C9466874F0](/claim/clm_42C9466874F0.md)
- 2016-02-29 to 2016-05-31 | quarterly_operating_income | 1,088,044,000 United States dollar | superseded | [clm_468D01AA87CB](/claim/clm_468D01AA87CB.md)
- 2016-02-29 to 2016-05-31 | quarterly_net_income | 1,326,520,000 United States dollar | superseded | [clm_5C25D90DCD58](/claim/clm_5C25D90DCD58.md)
- 2016-02-29 to 2016-05-31 | total_equity | 6,811,661,000 United States dollar | superseded | [clm_8CF20D49642F](/claim/clm_8CF20D49642F.md)
- 2016-05-31 to 2016-08-31 | total_assets | 19,191,047,000 United States dollar | superseded | [clm_74E9F0FA2DB3](/claim/clm_74E9F0FA2DB3.md)
- 2016-05-31 to 2016-11-30 | quarterly_revenue | 8,969,044,000 United States dollar | superseded | [clm_8508910D6C0D](/claim/clm_8508910D6C0D.md)
- 2016-05-31 to 2016-08-31 | total_equity | 7,127,325,000 United States dollar | superseded | [clm_8C6A7A0B680F](/claim/clm_8C6A7A0B680F.md)
- 2016-05-31 to 2016-08-31 | cash_and_equivalents | 3,497,878,000 United States dollar | superseded | [clm_ACCAEB189545](/claim/clm_ACCAEB189545.md)
- 2016-05-31 to 2016-11-30 | quarterly_operating_income | 1,305,943,000 United States dollar | superseded | [clm_AE20201F093C](/claim/clm_AE20201F093C.md)
- 2016-05-31 to 2016-11-30 | quarterly_net_income | 897,247,000 United States dollar | superseded | [clm_C24FFB13EDD4](/claim/clm_C24FFB13EDD4.md)
- 2016-07-13 | board_member | Nancy McKinstry | valid | [clm_CA3ADE3D5CF7](/claim/clm_CA3ADE3D5CF7.md)
- 2016-08-31 to 2016-11-30 | total_assets | 20,609,004,000 United States dollar | superseded | [clm_37F789796E52](/claim/clm_37F789796E52.md)
- 2016-08-31 to 2016-09-01 | operating_income | 4,810,445,000 United States dollar | superseded | [clm_4E3D19A48C6D](/claim/clm_4E3D19A48C6D.md)
- 2016-08-31 to 2016-11-30 | total_equity | 7,555,262,000 United States dollar | superseded | [clm_68A37E6A1ADA](/claim/clm_68A37E6A1ADA.md)
- 2016-08-31 to 2016-09-01 | revenue | 34,797,661,000 United States dollar | superseded | [clm_6D0EC0545123](/claim/clm_6D0EC0545123.md)
- 2016-08-31 to 2016-11-30 | cash_and_equivalents | 4,905,609,000 United States dollar | superseded | [clm_E698D685AD9A](/claim/clm_E698D685AD9A.md)
- 2016-08-31 to 2016-09-01 | net_income | 4,111,892,000 United States dollar | superseded | [clm_EBA4C012F31D](/claim/clm_EBA4C012F31D.md)
- 2016-08-31 to 2017-08-31 | research_and_development | 643,407,000 United States dollar | superseded | [clm_F7E618696B43](/claim/clm_F7E618696B43.md)
- 2016-09-01 to 2017-08-31 | operating_income | 5,191,402,000 United States dollar | superseded | [clm_03F72FBC8D60](/claim/clm_03F72FBC8D60.md)
- 2016-09-01 to 2017-08-31 | net_income | 3,445,149,000 United States dollar | superseded | [clm_06A9543AF4D6](/claim/clm_06A9543AF4D6.md)
- 2016-09-01 to 2017-08-31 | revenue | 36,176,841,000 United States dollar | superseded | [clm_59CD4D1155DD](/claim/clm_59CD4D1155DD.md)
- 2016-11-30 to 2017-02-28 | total_equity | 7,417,093,000 United States dollar | superseded | [clm_1A36BE425209](/claim/clm_1A36BE425209.md)
- 2016-11-30 to 2017-02-28 | quarterly_revenue | 9,005,603,000 United States dollar | superseded | [clm_2E11A930D375](/claim/clm_2E11A930D375.md)
- 2016-11-30 to 2017-02-28 | quarterly_net_income | 1,004,476,000 United States dollar | superseded | [clm_44CD560F4683](/claim/clm_44CD560F4683.md)
- 2016-11-30 to 2017-02-28 | cash_and_equivalents | 4,077,058,000 United States dollar | superseded | [clm_80C7CCE6A54D](/claim/clm_80C7CCE6A54D.md)
- 2016-11-30 to 2017-02-28 | total_assets | 20,443,741,000 United States dollar | superseded | [clm_A0E7D8287626](/claim/clm_A0E7D8287626.md)
- 2016-11-30 to 2017-02-28 | quarterly_operating_income | 1,331,959,000 United States dollar | superseded | [clm_FA04E5E42A58](/claim/clm_FA04E5E42A58.md)

## 2017

- 2017-02-28 to 2017-05-31 | total_equity | 7,964,245,000 United States dollar | superseded | [clm_9A9E37B7FD55](/claim/clm_9A9E37B7FD55.md)
- 2017-02-28 to 2017-05-31 | cash_and_equivalents | 3,238,862,000 United States dollar | superseded | [clm_9C352C8BC43F](/claim/clm_9C352C8BC43F.md)
- 2017-02-28 to 2017-05-31 | total_assets | 20,078,773,000 United States dollar | superseded | [clm_B85D756A4121](/claim/clm_B85D756A4121.md)
- 2017-02-28 to 2017-05-31 | quarterly_revenue | 8,762,182,000 United States dollar | superseded | [clm_C1BFBD0137F7](/claim/clm_C1BFBD0137F7.md)
- 2017-02-28 to 2017-05-31 | quarterly_operating_income | 1,138,653,000 United States dollar | superseded | [clm_C3FE228CB1FD](/claim/clm_C3FE228CB1FD.md)
- 2017-02-28 to 2017-05-31 | quarterly_net_income | 838,752,000 United States dollar | superseded | [clm_F3AE4AD88F99](/claim/clm_F3AE4AD88F99.md)
- 2017-05-31 to 2017-08-31 | total_assets | 21,135,592,000 United States dollar | superseded | [clm_497971D37A82](/claim/clm_497971D37A82.md)
- 2017-05-31 to 2017-08-31 | cash_and_equivalents | 3,382,208,000 United States dollar | superseded | [clm_9C5AA85D03CC](/claim/clm_9C5AA85D03CC.md)
- 2017-05-31 to 2017-11-30 | quarterly_revenue | 9,356,787,000 United States dollar | superseded | [clm_A856FB450ADF](/claim/clm_A856FB450ADF.md)
- 2017-05-31 to 2017-11-30 | quarterly_operating_income | 865,435,000 United States dollar | superseded | [clm_BD35CE44118E](/claim/clm_BD35CE44118E.md)
- 2017-05-31 to 2017-11-30 | quarterly_net_income | 669,468,000 United States dollar | superseded | [clm_D9A13BE6E333](/claim/clm_D9A13BE6E333.md)
- 2017-05-31 to 2017-08-31 | total_equity | 8,167,356,000 United States dollar | superseded | [clm_F006DB2AAFC7](/claim/clm_F006DB2AAFC7.md)
- 2017-07-20 | board_member | Tracey Travis | valid | [clm_3D3DC42E42CC](/claim/clm_3D3DC42E42CC.md)
- 2017-08-31 to 2017-09-01 | net_income | 3,445,149,000 United States dollar | superseded | [clm_06CD609CFE3A](/claim/clm_06CD609CFE3A.md)
- 2017-08-31 to 2017-09-01 | operating_income | 4,632,609,000 United States dollar | superseded | [clm_626A97A2DC9F](/claim/clm_626A97A2DC9F.md)
- 2017-08-31 to 2018-08-31 | research_and_development | 704,317,000 United States dollar | superseded | [clm_6AD6AEB1BDAD](/claim/clm_6AD6AEB1BDAD.md)
- 2017-08-31 to 2017-11-30 | cash_and_equivalents | 4,126,860,000 United States dollar | superseded | [clm_6C892E374F19](/claim/clm_6C892E374F19.md)
- 2017-08-31 to 2017-11-30 | total_equity | 8,949,477,000 United States dollar | superseded | [clm_995ECF5450FC](/claim/clm_995ECF5450FC.md)
- 2017-08-31 to 2017-11-30 | total_assets | 22,689,890,000 United States dollar | superseded | [clm_BFC4D0C1A5F3](/claim/clm_BFC4D0C1A5F3.md)
- 2017-08-31 to 2017-09-01 | revenue | 36,765,478,000 United States dollar | superseded | [clm_D4959E65388A](/claim/clm_D4959E65388A.md)
- 2017-09-01 to 2018-08-31 | net_income | 4,059,907,000 United States dollar | superseded | [clm_7E8A3EC8932A](/claim/clm_7E8A3EC8932A.md)
- 2017-09-01 to 2018-08-31 | operating_income | 5,898,779,000 United States dollar | superseded | [clm_A79D422CE0D1](/claim/clm_A79D422CE0D1.md)
- 2017-09-01 to 2018-08-31 | revenue | 40,992,534,000 United States dollar | superseded | [clm_D52E51DF0D70](/claim/clm_D52E51DF0D70.md)
- 2017-11-30 to 2018-02-28 | cash_and_equivalents | 3,681,711,000 United States dollar | superseded | [clm_1731BE7C662F](/claim/clm_1731BE7C662F.md)
- 2017-11-30 to 2018-02-28 | total_equity | 9,102,130,000 United States dollar | superseded | [clm_4C534C440B47](/claim/clm_4C534C440B47.md)
- 2017-11-30 to 2018-02-28 | quarterly_net_income | 1,123,660,000 United States dollar | superseded | [clm_6B6DA5E6445D](/claim/clm_6B6DA5E6445D.md)
- 2017-11-30 to 2018-02-28 | total_assets | 22,974,153,000 United States dollar | superseded | [clm_781B2FC0EBCA](/claim/clm_781B2FC0EBCA.md)
- 2017-11-30 to 2018-02-28 | quarterly_operating_income | 1,485,880,000 United States dollar | superseded | [clm_E6E772A90D6E](/claim/clm_E6E772A90D6E.md)
- 2017-11-30 to 2018-02-28 | quarterly_revenue | 10,054,493,000 United States dollar | superseded | [clm_E8530B80B477](/claim/clm_E8530B80B477.md)

## 2018

- 2018-02-28 to 2018-05-31 | total_equity | 9,682,687,000 United States dollar | superseded | [clm_104D51552837](/claim/clm_104D51552837.md)
- 2018-02-28 to 2018-05-31 | cash_and_equivalents | 3,595,079,000 United States dollar | superseded | [clm_3C46DC1143C3](/claim/clm_3C46DC1143C3.md)
- 2018-02-28 to 2018-05-31 | total_assets | 23,132,979,000 United States dollar | superseded | [clm_553E1CC8145A](/claim/clm_553E1CC8145A.md)
- 2018-02-28 to 2018-05-31 | quarterly_net_income | 863,703,000 United States dollar | superseded | [clm_63330EB9B741](/claim/clm_63330EB9B741.md)
- 2018-02-28 to 2018-05-31 | quarterly_revenue | 10,067,832,000 United States dollar | superseded | [clm_BAF6A33A4BA6](/claim/clm_BAF6A33A4BA6.md)
- 2018-02-28 to 2018-05-31 | quarterly_operating_income | 1,282,764,000 United States dollar | superseded | [clm_D76820B819F4](/claim/clm_D76820B819F4.md)
- 2018-04-12 | board_member | Venkata Renduchintala | valid | [clm_AFF263516E64](/claim/clm_AFF263516E64.md)
- 2018-05-31 to 2018-08-31 | cash_and_equivalents | 3,928,845,000 United States dollar | superseded | [clm_23038FB013DB](/claim/clm_23038FB013DB.md)
- 2018-05-31 to 2018-08-31 | total_equity | 9,797,325,000 United States dollar | superseded | [clm_3CBFDF943371](/claim/clm_3CBFDF943371.md)
- 2018-05-31 to 2018-11-30 | quarterly_net_income | 1,043,020,000 United States dollar | superseded | [clm_68C49BB1B783](/claim/clm_68C49BB1B783.md)
- 2018-05-31 to 2018-11-30 | quarterly_revenue | 10,838,854,000 United States dollar | superseded | [clm_D5B886AF4B23](/claim/clm_D5B886AF4B23.md)
- 2018-05-31 to 2018-11-30 | quarterly_operating_income | 1,619,726,000 United States dollar | superseded | [clm_E6B114A88125](/claim/clm_E6B114A88125.md)
- 2018-05-31 to 2018-08-31 | total_assets | 23,250,793,000 United States dollar | superseded | [clm_E974BC9C7B20](/claim/clm_E974BC9C7B20.md)
- 2018-08-31 to 2018-09-01 | revenue | 41,603,428,000 United States dollar | superseded | [clm_0A96CA8EA3AE](/claim/clm_0A96CA8EA3AE.md)
- 2018-08-31 to 2018-11-30 | cash_and_equivalents | 5,061,360,000 United States dollar | superseded | [clm_2659C7E24197](/claim/clm_2659C7E24197.md)
- 2018-08-31 to 2018-09-01 | net_income | 4,059,907,000 United States dollar | superseded | [clm_44522BEAA876](/claim/clm_44522BEAA876.md)
- 2018-08-31 to 2019-08-31 | research_and_development | 790,779,000 United States dollar | superseded | [clm_6332A9B51934](/claim/clm_6332A9B51934.md)
- 2018-08-31 to 2018-11-30 | total_equity | 10,364,753,000 United States dollar | superseded | [clm_7EA5E3F03E8B](/claim/clm_7EA5E3F03E8B.md)
- 2018-08-31 to 2018-09-01 | operating_income | 5,841,041,000 United States dollar | superseded | [clm_A3EC2855754C](/claim/clm_A3EC2855754C.md)
- 2018-08-31 to 2018-11-30 | total_assets | 24,449,083,000 United States dollar | superseded | [clm_CF97A49A35DD](/claim/clm_CF97A49A35DD.md)
- 2018-09-01 to 2019-08-31 | net_income | 4,779,112,000 United States dollar | superseded | [clm_13EF6AB8CC97](/claim/clm_13EF6AB8CC97.md)
- 2018-09-01 to 2019-08-31 | operating_income | 6,305,074,000 United States dollar | superseded | [clm_3DD52584C604](/claim/clm_3DD52584C604.md)
- 2018-09-01 to 2019-08-31 | revenue | 43,215,013,000 United States dollar | superseded | [clm_D1CD5A47D3C8](/claim/clm_D1CD5A47D3C8.md)
- 2018-11-30 to 2019-02-28 | quarterly_operating_income | 1,629,012,000 United States dollar | superseded | [clm_036A043FAB0B](/claim/clm_036A043FAB0B.md)
- 2018-11-30 to 2019-02-28 | quarterly_revenue | 10,605,546,000 United States dollar | superseded | [clm_369BDE68BAF4](/claim/clm_369BDE68BAF4.md)
- 2018-11-30 to 2019-02-28 | total_assets | 26,706,412,000 United States dollar | superseded | [clm_61662BD2FDD3](/claim/clm_61662BD2FDD3.md)
- 2018-11-30 to 2019-02-28 | total_equity | 12,678,856,000 United States dollar | superseded | [clm_666BD49ACF91](/claim/clm_666BD49ACF91.md)
- 2018-11-30 to 2019-02-28 | cash_and_equivalents | 4,363,790,000 United States dollar | superseded | [clm_845691AC79B5](/claim/clm_845691AC79B5.md)
- 2018-11-30 to 2019-02-28 | quarterly_net_income | 1,274,720,000 United States dollar | superseded | [clm_F0406F4FD543](/claim/clm_F0406F4FD543.md)

## 2019

- 2019-01-01 | ceo | Julie Sweet | valid | [clm_E3980AB54EDB](/claim/clm_E3980AB54EDB.md)
- 2019-02-28 to 2019-05-31 | quarterly_net_income | 1,124,449,000 United States dollar | superseded | [clm_1ADCC7A4E1EA](/claim/clm_1ADCC7A4E1EA.md)
- 2019-02-28 to 2019-05-31 | cash_and_equivalents | 4,464,889,000 United States dollar | superseded | [clm_42544D6A08E4](/claim/clm_42544D6A08E4.md)
- 2019-02-28 to 2019-05-31 | quarterly_revenue | 10,454,129,000 United States dollar | superseded | [clm_6CCCCAC4966C](/claim/clm_6CCCCAC4966C.md)
- 2019-02-28 to 2019-05-31 | quarterly_operating_income | 1,386,626,000 United States dollar | superseded | [clm_7220D5061956](/claim/clm_7220D5061956.md)
- 2019-02-28 to 2019-05-31 | total_equity | 13,337,033,000 United States dollar | superseded | [clm_9A2A3F4DA076](/claim/clm_9A2A3F4DA076.md)
- 2019-02-28 to 2019-05-31 | total_assets | 27,390,208,000 United States dollar | superseded | [clm_B0B4D7266755](/claim/clm_B0B4D7266755.md)
- 2019-05-31 to 2019-11-30 | quarterly_operating_income | 1,717,943,000 United States dollar | superseded | [clm_16DA9A3174D7](/claim/clm_16DA9A3174D7.md)
- 2019-05-31 to 2019-08-31 | total_assets | 28,156,360,000 United States dollar | superseded | [clm_49F9641C3C3F](/claim/clm_49F9641C3C3F.md)
- 2019-05-31 to 2019-08-31 | cash_and_equivalents | 4,769,158,000 United States dollar | superseded | [clm_5DD8151A096A](/claim/clm_5DD8151A096A.md)
- 2019-05-31 to 2019-11-30 | quarterly_revenue | 11,099,688,000 United States dollar | superseded | [clm_71F6088B85DD](/claim/clm_71F6088B85DD.md)
- 2019-05-31 to 2019-08-31 | total_equity | 13,737,324,000 United States dollar | superseded | [clm_998AC7411E93](/claim/clm_998AC7411E93.md)
- 2019-05-31 to 2019-11-30 | quarterly_net_income | 1,249,516,000 United States dollar | superseded | [clm_E88BC66177F4](/claim/clm_E88BC66177F4.md)
- 2019-08-31 to 2019-11-30 | cash_and_equivalents | 6,126,853,000 United States dollar | superseded | [clm_62A808D8FF1E](/claim/clm_62A808D8FF1E.md)
- 2019-08-31 to 2019-09-01 | net_income | 4,779,112,000 United States dollar | superseded | [clm_74200AC33FA4](/claim/clm_74200AC33FA4.md)
- 2019-08-31 to 2020-08-31 | research_and_development | 799,734,000 United States dollar | superseded | [clm_BA63C8B81FED](/claim/clm_BA63C8B81FED.md)
- 2019-08-31 to 2019-11-30 | total_assets | 29,789,880,000 United States dollar | superseded | [clm_C9FAA3CE971E](/claim/clm_C9FAA3CE971E.md)
- 2019-08-31 to 2019-11-30 | total_equity | 14,409,008,000 United States dollar | superseded | [clm_CB8D40DFC8CB](/claim/clm_CB8D40DFC8CB.md)
- 2019-08-31 to 2019-09-01 | revenue | 43,215,013,000 United States dollar | superseded | [clm_D5DAB2B78E5C](/claim/clm_D5DAB2B78E5C.md)
- 2019-08-31 to 2019-09-01 | operating_income | 6,305,074,000 United States dollar | superseded | [clm_FF732D1007B0](/claim/clm_FF732D1007B0.md)
- 2019-09-01 | board_member | Julie Sweet | valid | [clm_71FFC79CB19B](/claim/clm_71FFC79CB19B.md)
- 2019-09-01 to 2020-08-31 | net_income | 5,107,839,000 United States dollar | superseded | [clm_8C0100A50D1A](/claim/clm_8C0100A50D1A.md)
- 2019-09-01 to 2020-08-31 | revenue | 44,327,039,000 United States dollar | superseded | [clm_D42689C5B382](/claim/clm_D42689C5B382.md)
- 2019-09-01 to 2020-08-31 | operating_income | 6,513,644,000 United States dollar | superseded | [clm_D9E732A12865](/claim/clm_D9E732A12865.md)
- 2019-11-30 to 2020-02-29 | total_equity | 15,167,138,000 United States dollar | superseded | [clm_016CC2D725B7](/claim/clm_016CC2D725B7.md)
- 2019-11-30 to 2020-02-29 | cash_and_equivalents | 5,810,537,000 United States dollar | superseded | [clm_1958BEACE147](/claim/clm_1958BEACE147.md)
- 2019-11-30 to 2020-02-29 | quarterly_revenue | 11,358,958,000 United States dollar | superseded | [clm_5559383ABA7E](/claim/clm_5559383ABA7E.md)
- 2019-11-30 to 2020-02-29 | quarterly_operating_income | 1,767,263,000 United States dollar | superseded | [clm_8B1A167C0C9C](/claim/clm_8B1A167C0C9C.md)
- 2019-11-30 to 2020-02-29 | quarterly_net_income | 1,356,968,000 United States dollar | superseded | [clm_D8835301D4FC](/claim/clm_D8835301D4FC.md)
- 2019-11-30 to 2020-02-29 | total_assets | 33,170,712,000 United States dollar | superseded | [clm_F46B541460F4](/claim/clm_F46B541460F4.md)

## 2020

- 2020-02-29 to 2020-05-31 | quarterly_revenue | 11,141,505,000 United States dollar | superseded | [clm_0055D29684D1](/claim/clm_0055D29684D1.md)
- 2020-02-29 to 2020-05-31 | quarterly_operating_income | 1,488,945,000 United States dollar | superseded | [clm_1D745A340B76](/claim/clm_1D745A340B76.md)
- 2020-02-29 to 2020-05-31 | total_equity | 15,474,589,000 United States dollar | superseded | [clm_44558CB76922](/claim/clm_44558CB76922.md)
- 2020-02-29 to 2020-05-31 | total_assets | 33,503,430,000 United States dollar | superseded | [clm_54BB0DD3B6B5](/claim/clm_54BB0DD3B6B5.md)
- 2020-02-29 to 2020-05-31 | quarterly_net_income | 1,234,740,000 United States dollar | superseded | [clm_E4828215E49E](/claim/clm_E4828215E49E.md)
- 2020-02-29 to 2020-05-31 | cash_and_equivalents | 5,436,456,000 United States dollar | superseded | [clm_E5B61CC3A273](/claim/clm_E5B61CC3A273.md)
- 2020-05-31 to 2020-11-30 | quarterly_net_income | 1,228,202,000 United States dollar | superseded | [clm_03E51628B230](/claim/clm_03E51628B230.md)
- 2020-05-31 to 2020-11-30 | quarterly_operating_income | 1,712,733,000 United States dollar | superseded | [clm_0FEB0A02CD50](/claim/clm_0FEB0A02CD50.md)
- 2020-05-31 to 2020-08-31 | cash_and_equivalents | 6,442,261,000 United States dollar | superseded | [clm_2C79A8D3D902](/claim/clm_2C79A8D3D902.md)
- 2020-05-31 to 2020-08-31 | total_assets | 35,057,319,000 United States dollar | superseded | [clm_7E5EDD782DD0](/claim/clm_7E5EDD782DD0.md)
- 2020-05-31 to 2020-08-31 | total_equity | 16,014,606,000 United States dollar | superseded | [clm_D186E37EEE3B](/claim/clm_D186E37EEE3B.md)
- 2020-05-31 to 2020-11-30 | quarterly_revenue | 10,991,305,000 United States dollar | superseded | [clm_F3A739E29994](/claim/clm_F3A739E29994.md)
- 2020-08-31 to 2020-11-30 | total_assets | 37,078,593,000 United States dollar | superseded | [clm_3844B548272D](/claim/clm_3844B548272D.md)
- 2020-08-31 to 2020-09-01 | operating_income | 6,513,644,000 United States dollar | superseded | [clm_64079790FE2B](/claim/clm_64079790FE2B.md)
- 2020-08-31 to 2020-09-01 | net_income | 5,107,839,000 United States dollar | superseded | [clm_6B981ACB4D69](/claim/clm_6B981ACB4D69.md)
- 2020-08-31 to 2020-11-30 | cash_and_equivalents | 8,415,330,000 United States dollar | superseded | [clm_726C2EFD4CF2](/claim/clm_726C2EFD4CF2.md)
- 2020-08-31 to 2021-08-31 | research_and_development | 870,611,000 United States dollar | superseded | [clm_74FE0ECE66D5](/claim/clm_74FE0ECE66D5.md)
- 2020-08-31 to 2020-09-01 | revenue | 44,327,039,000 United States dollar | superseded | [clm_832EE84CB2BE](/claim/clm_832EE84CB2BE.md)
- 2020-08-31 to 2020-11-30 | total_equity | 17,000,536,000 United States dollar | superseded | [clm_D9E654EC76DE](/claim/clm_D9E654EC76DE.md)
- 2020-09-01 to 2021-08-31 | operating_income | 7,621,529,000 United States dollar | superseded | [clm_B71E461C7321](/claim/clm_B71E461C7321.md)
- 2020-09-01 to 2021-08-31 | revenue | 50,533,389,000 United States dollar | superseded | [clm_CCF83092D01B](/claim/clm_CCF83092D01B.md)
- 2020-09-01 to 2021-08-31 | net_income | 5,906,809,000 United States dollar | superseded | [clm_DB1299973D17](/claim/clm_DB1299973D17.md)
- 2020-11-30 to 2021-02-28 | cash_and_equivalents | 8,594,003,000 United States dollar | superseded | [clm_1C5E84C32A59](/claim/clm_1C5E84C32A59.md)
- 2020-11-30 to 2021-02-28 | total_assets | 38,268,311,000 United States dollar | superseded | [clm_1E1F156A7D2C](/claim/clm_1E1F156A7D2C.md)
- 2020-11-30 to 2021-02-28 | quarterly_net_income | 1,500,276,000 United States dollar | superseded | [clm_4A403DF1C556](/claim/clm_4A403DF1C556.md)
- 2020-11-30 to 2021-02-28 | quarterly_operating_income | 1,890,669,000 United States dollar | superseded | [clm_74EF965E0DAE](/claim/clm_74EF965E0DAE.md)
- 2020-11-30 to 2021-02-28 | total_equity | 17,906,501,000 United States dollar | superseded | [clm_8EC708993D44](/claim/clm_8EC708993D44.md)
- 2020-11-30 to 2021-02-28 | quarterly_revenue | 11,762,185,000 United States dollar | superseded | [clm_E7C75DADC6A0](/claim/clm_E7C75DADC6A0.md)

## 2021

- 2021-02-02 | board_member | Beth E. Mooney | valid | [clm_147649D5BA7C](/claim/clm_147649D5BA7C.md)
- 2021-02-28 to 2021-05-31 | quarterly_revenue | 12,088,125,000 United States dollar | superseded | [clm_2317F50315AD](/claim/clm_2317F50315AD.md)
- 2021-02-28 to 2021-05-31 | total_equity | 18,308,027,000 United States dollar | superseded | [clm_349D9799807C](/claim/clm_349D9799807C.md)
- 2021-02-28 to 2021-05-31 | total_assets | 39,985,401,000 United States dollar | superseded | [clm_5DF23E42113D](/claim/clm_5DF23E42113D.md)
- 2021-02-28 to 2021-05-31 | cash_and_equivalents | 9,166,578,000 United States dollar | superseded | [clm_638D15B2EA39](/claim/clm_638D15B2EA39.md)
- 2021-02-28 to 2021-05-31 | quarterly_net_income | 1,440,859,000 United States dollar | superseded | [clm_9345DA27B248](/claim/clm_9345DA27B248.md)
- 2021-02-28 to 2021-05-31 | quarterly_operating_income | 1,653,515,000 United States dollar | superseded | [clm_A39168CFA712](/claim/clm_A39168CFA712.md)
- 2021-05-31 to 2021-08-31 | total_equity | 19,342,845,000 United States dollar | superseded | [clm_009E103A1CF8](/claim/clm_009E103A1CF8.md)
- 2021-05-31 to 2021-11-30 | quarterly_net_income | 1,549,426,000 United States dollar | superseded | [clm_19C6D12FEB26](/claim/clm_19C6D12FEB26.md)
- 2021-05-31 to 2021-08-31 | cash_and_equivalents | 10,009,380,000 United States dollar | superseded | [clm_79B5054763CE](/claim/clm_79B5054763CE.md)
- 2021-05-31 to 2021-11-30 | quarterly_revenue | 13,263,795,000 United States dollar | superseded | [clm_8A45A7653411](/claim/clm_8A45A7653411.md)
- 2021-05-31 to 2021-11-30 | quarterly_operating_income | 2,118,656,000 United States dollar | superseded | [clm_90CE769D5AE5](/claim/clm_90CE769D5AE5.md)
- 2021-05-31 to 2021-08-31 | total_assets | 42,124,884,000 United States dollar | superseded | [clm_F8E25AE907A0](/claim/clm_F8E25AE907A0.md)
- 2021-08-31 to 2022-08-31 | revenue | 50,533,389,000 United States dollar | superseded | [clm_0460D7559B57](/claim/clm_0460D7559B57.md)
- 2021-08-31 to 2021-09-01 | net_income | 5,906,809,000 United States dollar | superseded | [clm_2D663B2D3239](/claim/clm_2D663B2D3239.md)
- 2021-08-31 to 2021-09-01 | operating_income | 7,621,529,000 United States dollar | superseded | [clm_4E1D3F3F099E](/claim/clm_4E1D3F3F099E.md)
- 2021-08-31 to 2021-11-30 | cash_and_equivalents | 8,168,174,000 United States dollar | superseded | [clm_7A4E1EA3D370](/claim/clm_7A4E1EA3D370.md)
- 2021-08-31 to 2022-08-31 | research_and_development | 1,118,320,000 United States dollar | superseded | [clm_C163D9544617](/claim/clm_C163D9544617.md)
- 2021-08-31 to 2021-11-30 | total_equity | 19,529,454,000 United States dollar | superseded | [clm_D26126F3D11F](/claim/clm_D26126F3D11F.md)
- 2021-08-31 to 2021-11-30 | total_assets | 43,175,843,000 United States dollar | superseded | [clm_E2390D1A0114](/claim/clm_E2390D1A0114.md)
- 2021-09-01 to 2022-08-31 | operating_income | 9,367,181,000 United States dollar | superseded | [clm_09FC77C7D985](/claim/clm_09FC77C7D985.md)
- 2021-09-01 to 2022-08-31 | net_income | 6,877,169,000 United States dollar | superseded | [clm_BFE47354D5D7](/claim/clm_BFE47354D5D7.md)
- 2021-11-30 to 2022-02-28 | cash_and_equivalents | 5,637,117,000 United States dollar | superseded | [clm_12FDFB40FFCF](/claim/clm_12FDFB40FFCF.md)
- 2021-11-30 to 2022-02-28 | total_assets | 43,674,743,000 United States dollar | superseded | [clm_187A1D16AA1B](/claim/clm_187A1D16AA1B.md)
- 2021-11-30 to 2022-02-28 | total_equity | 20,353,199,000 United States dollar | superseded | [clm_1FDC93AD3A7A](/claim/clm_1FDC93AD3A7A.md)
- 2021-11-30 to 2022-02-28 | quarterly_net_income | 1,791,024,000 United States dollar | superseded | [clm_34638ED30963](/claim/clm_34638ED30963.md)
- 2021-11-30 to 2022-02-28 | quarterly_revenue | 14,965,153,000 United States dollar | superseded | [clm_3BAF9032483A](/claim/clm_3BAF9032483A.md)
- 2021-11-30 to 2022-02-28 | quarterly_operating_income | 2,434,294,000 United States dollar | superseded | [clm_F5C4FAD7EF98](/claim/clm_F5C4FAD7EF98.md)

## 2022

- 2022-02-28 to 2022-05-31 | quarterly_net_income | 1,634,942,000 United States dollar | superseded | [clm_0F53D1D42526](/claim/clm_0F53D1D42526.md)
- 2022-02-28 to 2022-05-31 | quarterly_operating_income | 2,061,580,000 United States dollar | superseded | [clm_333656E0883E](/claim/clm_333656E0883E.md)
- 2022-02-28 to 2022-05-31 | total_assets | 44,317,837,000 United States dollar | superseded | [clm_44FCF641F76C](/claim/clm_44FCF641F76C.md)
- 2022-02-28 to 2022-05-31 | quarterly_revenue | 15,046,693,000 United States dollar | superseded | [clm_7DE52993EEFD](/claim/clm_7DE52993EEFD.md)
- 2022-02-28 to 2022-05-31 | total_equity | 20,560,023,000 United States dollar | superseded | [clm_8A97CC1157C3](/claim/clm_8A97CC1157C3.md)
- 2022-02-28 to 2022-05-31 | cash_and_equivalents | 5,466,116,000 United States dollar | superseded | [clm_DD95169D6278](/claim/clm_DD95169D6278.md)
- 2022-05-31 to 2022-11-30 | quarterly_revenue | 16,158,803,000 United States dollar | superseded | [clm_17FEE4D2924D](/claim/clm_17FEE4D2924D.md)
- 2022-05-31 to 2022-08-31 | total_equity | 21,389,094,000 United States dollar | superseded | [clm_26AAACBD0365](/claim/clm_26AAACBD0365.md)
- 2022-05-31 to 2022-11-30 | quarterly_net_income | 1,786,075,000 United States dollar | superseded | [clm_31A1916DE569](/claim/clm_31A1916DE569.md)
- 2022-05-31 to 2022-08-31 | total_assets | 46,095,198,000 United States dollar | superseded | [clm_4DBF122984BF](/claim/clm_4DBF122984BF.md)
- 2022-05-31 to 2022-08-31 | cash_and_equivalents | 6,703,568,000 United States dollar | superseded | [clm_5073D31880DA](/claim/clm_5073D31880DA.md)
- 2022-05-31 to 2022-11-30 | quarterly_operating_income | 2,603,118,000 United States dollar | superseded | [clm_D00A22828A16](/claim/clm_D00A22828A16.md)
- 2022-08-31 to 2023-08-31 | research_and_development | 1,123,296,000 United States dollar | superseded | [clm_3EFB5CADE872](/claim/clm_3EFB5CADE872.md)
- 2022-08-31 to 2022-11-30 | cash_and_equivalents | 7,889,833,000 United States dollar | superseded | [clm_A6A491A6D2F0](/claim/clm_A6A491A6D2F0.md)
- 2022-08-31 to 2022-09-01 | operating_income | 9,367,181,000 United States dollar | superseded | [clm_AD577670A524](/claim/clm_AD577670A524.md)
- 2022-08-31 to 2022-11-30 | total_assets | 47,263,390,000 United States dollar | superseded | [clm_C7A79B9C6934](/claim/clm_C7A79B9C6934.md)
- 2022-08-31 to 2022-11-30 | total_equity | 22,106,097,000 United States dollar | superseded | [clm_D85516B56821](/claim/clm_D85516B56821.md)
- 2022-08-31 to 2022-09-01 | net_income | 6,877,169,000 United States dollar | superseded | [clm_DB4022E81583](/claim/clm_DB4022E81583.md)
- 2022-08-31 to 2022-09-01 | revenue | 61,594,305,000 United States dollar | superseded | [clm_F88741C71883](/claim/clm_F88741C71883.md)
- 2022-09-01 to 2023-08-31 | revenue | 64,111,745,000 United States dollar | superseded | [clm_346A4B6D0B27](/claim/clm_346A4B6D0B27.md)
- 2022-09-01 to 2023-08-31 | operating_income | 8,809,889,000 United States dollar | superseded | [clm_8EF035418F0C](/claim/clm_8EF035418F0C.md)
- 2022-11-30 to 2023-02-28 | quarterly_net_income | 1,964,950,000 United States dollar | superseded | [clm_0D8B7427669D](/claim/clm_0D8B7427669D.md)
- 2022-11-30 to 2023-02-28 | total_assets | 47,115,774,000 United States dollar | superseded | [clm_15F121EBFA6D](/claim/clm_15F121EBFA6D.md)
- 2022-11-30 to 2023-02-28 | total_equity | 22,974,611,000 United States dollar | superseded | [clm_195B70AE24E9](/claim/clm_195B70AE24E9.md)
- 2022-11-30 to 2023-02-28 | cash_and_equivalents | 5,899,703,000 United States dollar | superseded | [clm_2EB87A15EF5E](/claim/clm_2EB87A15EF5E.md)
- 2022-11-30 to 2023-02-28 | quarterly_operating_income | 2,593,100,000 United States dollar | superseded | [clm_2EF0F2EC9C13](/claim/clm_2EF0F2EC9C13.md)
- 2022-11-30 to 2023-02-28 | quarterly_revenue | 15,747,802,000 United States dollar | superseded | [clm_64D6CDEAB12A](/claim/clm_64D6CDEAB12A.md)

## 2023

- 2023-02-28 to 2023-05-31 | quarterly_operating_income | 1,944,581,000 United States dollar | superseded | [clm_46837C73E656](/claim/clm_46837C73E656.md)
- 2023-02-28 to 2023-05-31 | quarterly_net_income | 1,523,648,000 United States dollar | superseded | [clm_732A3F66039D](/claim/clm_732A3F66039D.md)
- 2023-02-28 to 2023-05-31 | total_equity | 23,762,619,000 United States dollar | superseded | [clm_7586240A631D](/claim/clm_7586240A631D.md)
- 2023-02-28 to 2023-05-31 | total_assets | 47,727,289,000 United States dollar | superseded | [clm_B612E23F3A90](/claim/clm_B612E23F3A90.md)
- 2023-02-28 to 2023-05-31 | quarterly_revenue | 15,814,158,000 United States dollar | superseded | [clm_BE7AF995C78B](/claim/clm_BE7AF995C78B.md)
- 2023-02-28 to 2023-05-31 | cash_and_equivalents | 6,238,787,000 United States dollar | superseded | [clm_E948D53A3A75](/claim/clm_E948D53A3A75.md)
- 2023-04-14 | board_member | Alan Jope | unverified | [clm_DF3F8F784FCF](/claim/clm_DF3F8F784FCF.md)
- 2023-05-31 to 2023-11-30 | quarterly_operating_income | 2,359,288,000 United States dollar | superseded | [clm_0AE17727106F](/claim/clm_0AE17727106F.md)
- 2023-05-31 to 2023-11-30 | quarterly_revenue | 16,564,585,000 United States dollar | superseded | [clm_3A2A20F193C7](/claim/clm_3A2A20F193C7.md)
- 2023-05-31 to 2023-08-31 | total_equity | 25,332,431,000 United States dollar | superseded | [clm_690C14EA40A8](/claim/clm_690C14EA40A8.md)
- 2023-05-31 to 2023-11-30 | quarterly_net_income | 2,009,996,000 United States dollar | superseded | [clm_A9EED88E061A](/claim/clm_A9EED88E061A.md)
- 2023-05-31 to 2023-08-31 | total_assets | 50,128,275,000 United States dollar | superseded | [clm_E68BCBB6AB59](/claim/clm_E68BCBB6AB59.md)
- 2023-05-31 to 2023-08-31 | cash_and_equivalents | 8,535,446,000 United States dollar | superseded | [clm_E72105348844](/claim/clm_E72105348844.md)
- 2023-08-31 to 2023-11-30 | total_assets | 51,245,305,000 United States dollar | superseded | [clm_0BA4A96174E6](/claim/clm_0BA4A96174E6.md)
- 2023-08-31 to 2024-08-31 | research_and_development | 1,298,657,000 United States dollar | superseded | [clm_4FB65CBD55DF](/claim/clm_4FB65CBD55DF.md)
- 2023-08-31 to 2023-09-01 | net_income | 6,871,557,000 United States dollar | superseded | [clm_59830F00BAAE](/claim/clm_59830F00BAAE.md)
- 2023-08-31 to 2023-09-01 | operating_income | 8,809,889,000 United States dollar | superseded | [clm_68E7DD475026](/claim/clm_68E7DD475026.md)
- 2023-08-31 to 2023-11-30 | total_equity | 25,692,839,000 United States dollar | superseded | [clm_AE6935E3F08F](/claim/clm_AE6935E3F08F.md)
- 2023-08-31 to 2023-09-01 | revenue | 64,111,745,000 United States dollar | superseded | [clm_B392D4A97C81](/claim/clm_B392D4A97C81.md)
- 2023-08-31 to 2023-11-30 | cash_and_equivalents | 9,045,032,000 United States dollar | superseded | [clm_F8BD89550279](/claim/clm_F8BD89550279.md)
- 2023-09-01 | coo | John Walsh | valid | [clm_413033F3CD21](/claim/clm_413033F3CD21.md)
- 2023-09-01 to 2024-08-31 | net_income | 7,264,787,000 United States dollar | superseded | [clm_889914EA3E53](/claim/clm_889914EA3E53.md)
- 2023-09-01 to 2024-08-31 | revenue | 64,896,464,000 United States dollar | superseded | [clm_976C25BDE51A](/claim/clm_976C25BDE51A.md)
- 2023-09-01 to 2024-08-31 | operating_income | 9,595,847,000 United States dollar | superseded | [clm_DEB880FD29DB](/claim/clm_DEB880FD29DB.md)
- 2023-10-31 to 2024-03-01 | employees | 733,000 | superseded | [clm_4B2BCBDB8C3D](/claim/clm_4B2BCBDB8C3D.md)
- 2023-11-30 to 2024-02-29 | total_assets | 51,531,354,000 United States dollar | superseded | [clm_722CFCA6C92F](/claim/clm_722CFCA6C92F.md)
- 2023-11-30 to 2024-02-29 | quarterly_net_income | 1,973,444,000 United States dollar | superseded | [clm_72DB8C942A16](/claim/clm_72DB8C942A16.md)
- 2023-11-30 to 2024-02-29 | cash_and_equivalents | 7,140,841,000 United States dollar | superseded | [clm_7CDA6E20194B](/claim/clm_7CDA6E20194B.md)
- 2023-11-30 to 2024-02-29 | quarterly_revenue | 16,224,303,000 United States dollar | superseded | [clm_871478AE09DF](/claim/clm_871478AE09DF.md)
- 2023-11-30 to 2024-02-29 | quarterly_operating_income | 2,564,887,000 United States dollar | superseded | [clm_BA1127DD8AEE](/claim/clm_BA1127DD8AEE.md)
- 2023-11-30 to 2024-02-29 | total_equity | 26,676,751,000 United States dollar | superseded | [clm_D6EEAEAB57A9](/claim/clm_D6EEAEAB57A9.md)

## 2024

- 2024-01-31 | board_member | Martin Brudermüller | valid | [clm_896FE2AAE303](/claim/clm_896FE2AAE303.md)
- 2024-02-29 to 2024-05-31 | quarterly_revenue | 15,799,514,000 United States dollar | superseded | [clm_18BA26274DD8](/claim/clm_18BA26274DD8.md)
- 2024-02-29 to 2024-05-31 | total_assets | 51,307,471,000 United States dollar | superseded | [clm_60F5AF83D49F](/claim/clm_60F5AF83D49F.md)
- 2024-02-29 to 2024-05-31 | quarterly_net_income | 1,674,859,000 United States dollar | superseded | [clm_613161CCA055](/claim/clm_613161CCA055.md)
- 2024-02-29 to 2024-05-31 | quarterly_operating_income | 2,046,427,000 United States dollar | superseded | [clm_93C834C4468B](/claim/clm_93C834C4468B.md)
- 2024-02-29 to 2024-05-31 | cash_and_equivalents | 5,121,107,000 United States dollar | superseded | [clm_D760A9100E77](/claim/clm_D760A9100E77.md)
- 2024-02-29 to 2024-05-31 | total_equity | 27,122,853,000 United States dollar | superseded | [clm_DBCD9143DF96](/claim/clm_DBCD9143DF96.md)
- 2024-03-01 to 2025-08-31 | employees | 742,000 | superseded | [clm_BF99A38EC8E4](/claim/clm_BF99A38EC8E4.md)
- 2024-05-31 to 2024-11-30 | quarterly_net_income | 1,932,183,000 United States dollar | superseded | [clm_370BF549D4DE](/claim/clm_370BF549D4DE.md)
- 2024-05-31 to 2024-08-31 | total_assets | 54,141,319,000 United States dollar | superseded | [clm_3C22627522A1](/claim/clm_3C22627522A1.md)
- 2024-05-31 to 2024-08-31 | cash_and_equivalents | 5,537,217,000 United States dollar | superseded | [clm_4B464AE28687](/claim/clm_4B464AE28687.md)
- 2024-05-31 to 2024-11-30 | quarterly_operating_income | 2,630,865,000 United States dollar | superseded | [clm_A4A67ED8DE4F](/claim/clm_A4A67ED8DE4F.md)
- 2024-05-31 to 2024-11-30 | quarterly_revenue | 16,466,828,000 United States dollar | superseded | [clm_A67B1E82843E](/claim/clm_A67B1E82843E.md)
- 2024-05-31 to 2024-08-31 | total_equity | 27,744,489,000 United States dollar | superseded | [clm_D3E82052F5C8](/claim/clm_D3E82052F5C8.md)
- 2024-08-31 to 2024-11-30 | cash_and_equivalents | 5,004,469,000 United States dollar | superseded | [clm_432435647680](/claim/clm_432435647680.md)
- 2024-08-31 to 2025-08-31 | research_and_development | 1,150,430,000 United States dollar | superseded | [clm_4D30335D4EEA](/claim/clm_4D30335D4EEA.md)
- 2024-08-31 to 2024-09-01 | revenue | 64,896,464,000 United States dollar | superseded | [clm_666DB11A0A09](/claim/clm_666DB11A0A09.md)
- 2024-08-31 to 2024-09-01 | operating_income | 9,595,847,000 United States dollar | superseded | [clm_7A95491DAA55](/claim/clm_7A95491DAA55.md)
- 2024-08-31 to 2024-11-30 | total_equity | 28,288,646,000 United States dollar | superseded | [clm_7CB87ABA5837](/claim/clm_7CB87ABA5837.md)
- 2024-08-31 to 2024-11-30 | total_assets | 55,932,363,000 United States dollar | superseded | [clm_8CFED8D58C28](/claim/clm_8CFED8D58C28.md)
- 2024-08-31 to 2024-09-01 | net_income | 7,264,787,000 United States dollar | superseded | [clm_FFC2446BC84C](/claim/clm_FFC2446BC84C.md)
- 2024-09-01 to 2025-08-31 | revenue | 69,672,977,000 United States dollar | superseded | [clm_27CE94166C2B](/claim/clm_27CE94166C2B.md)
- 2024-09-01 to 2025-08-31 | net_income | 7,678,433,000 United States dollar | superseded | [clm_A19B8B5E33CE](/claim/clm_A19B8B5E33CE.md)
- 2024-09-01 to 2025-08-31 | operating_income | 10,225,664,000 United States dollar | superseded | [clm_DF7CE6D4C6D4](/claim/clm_DF7CE6D4C6D4.md)
- 2024-11-30 to 2025-02-28 | total_equity | 29,190,495,000 United States dollar | superseded | [clm_08BDEE4EA0D0](/claim/clm_08BDEE4EA0D0.md)
- 2024-11-30 to 2025-02-28 | total_assets | 59,868,070,000 United States dollar | superseded | [clm_27B0F55566A0](/claim/clm_27B0F55566A0.md)
- 2024-11-30 to 2025-02-28 | quarterly_operating_income | 2,948,477,000 United States dollar | superseded | [clm_2AAB5A17B7CF](/claim/clm_2AAB5A17B7CF.md)
- 2024-11-30 to 2025-02-28 | quarterly_net_income | 2,278,894,000 United States dollar | superseded | [clm_491FC548684E](/claim/clm_491FC548684E.md)
- 2024-11-30 to 2025-02-28 | quarterly_revenue | 17,689,545,000 United States dollar | superseded | [clm_4E87C7ED924C](/claim/clm_4E87C7ED924C.md)
- 2024-11-30 to 2025-02-28 | cash_and_equivalents | 8,306,055,000 United States dollar | superseded | [clm_6C138D1E22AB](/claim/clm_6C138D1E22AB.md)
- 2024-12-01 | cfo | Angie Park | valid | [clm_933BD97ADF37](/claim/clm_933BD97ADF37.md)

## 2025

- 2025-02-28 to 2025-05-31 | total_equity | 29,246,053,000 United States dollar | superseded | [clm_25F5C334A5C2](/claim/clm_25F5C334A5C2.md)
- 2025-02-28 to 2025-05-31 | quarterly_revenue | 16,659,301,000 United States dollar | superseded | [clm_2B5E913BF39B](/claim/clm_2B5E913BF39B.md)
- 2025-02-28 to 2025-05-31 | quarterly_net_income | 1,788,075,000 United States dollar | superseded | [clm_67710267466A](/claim/clm_67710267466A.md)
- 2025-02-28 to 2025-05-31 | total_assets | 59,869,756,000 United States dollar | superseded | [clm_9805EF29AD36](/claim/clm_9805EF29AD36.md)
- 2025-02-28 to 2025-05-31 | cash_and_equivalents | 8,490,438,000 United States dollar | superseded | [clm_C49511FE46B3](/claim/clm_C49511FE46B3.md)
- 2025-02-28 to 2025-05-31 | quarterly_operating_income | 2,244,714,000 United States dollar | superseded | [clm_D436FF1BCE17](/claim/clm_D436FF1BCE17.md)
- 2025-05-31 to 2025-11-30 | quarterly_net_income | 2,197,501,000 United States dollar | superseded | [clm_0C17ECC99FA5](/claim/clm_0C17ECC99FA5.md)
- 2025-05-31 to 2025-11-30 | quarterly_operating_income | 2,982,782,000 United States dollar | superseded | [clm_6C80E2F9E14D](/claim/clm_6C80E2F9E14D.md)
- 2025-05-31 to 2025-08-31 | total_assets | 63,362,028,000 United States dollar | superseded | [clm_969070D169FB](/claim/clm_969070D169FB.md)
- 2025-05-31 to 2025-08-31 | cash_and_equivalents | 9,631,607,000 United States dollar | superseded | [clm_DCD8145FF7D1](/claim/clm_DCD8145FF7D1.md)
- 2025-05-31 to 2025-08-31 | total_equity | 30,554,725,000 United States dollar | superseded | [clm_EFD39AC57A40](/claim/clm_EFD39AC57A40.md)
- 2025-05-31 to 2025-11-30 | quarterly_revenue | 17,727,871,000 United States dollar | superseded | [clm_F30C248DA446](/claim/clm_F30C248DA446.md)
- 2025-08-31 | employees | 779,000 | valid | [clm_01236965B0CF](/claim/clm_01236965B0CF.md)
- 2025-08-31 to 2025-11-30 | total_assets | 65,394,897,000 United States dollar | superseded | [clm_23681A918021](/claim/clm_23681A918021.md)
- 2025-08-31 to 2025-11-30 | cash_and_equivalents | 11,478,729,000 United States dollar | superseded | [clm_2FAF73773C59](/claim/clm_2FAF73773C59.md)
- 2025-08-31 to 2026-08-31 | net_income | 7,678,433,000 United States dollar | superseded | [clm_4FC7570D7E2F](/claim/clm_4FC7570D7E2F.md)
- 2025-08-31 to 2026-08-31 | operating_income | 10,225,664,000 United States dollar | superseded | [clm_9AD4F53F20BE](/claim/clm_9AD4F53F20BE.md)
- 2025-08-31 to 2026-08-31 | research_and_development | 817,300,000 United States dollar | superseded | [clm_A25AF5400AEA](/claim/clm_A25AF5400AEA.md)
- 2025-08-31 to 2026-08-31 | revenue | 69,672,977,000 United States dollar | superseded | [clm_B234BA41B701](/claim/clm_B234BA41B701.md)
- 2025-08-31 to 2025-11-30 | total_equity | 31,195,446,000 United States dollar | superseded | [clm_DBA99D4BC412](/claim/clm_DBA99D4BC412.md)
- 2025-09-01 | coo | Kate Hogan | valid | [clm_B8DFD5304E4F](/claim/clm_B8DFD5304E4F.md)
- 2025-10-01 to 2026-10-28 | market_cap | 151,580,000,000 United States dollar | superseded | [clm_2DF3D584C47C](/claim/clm_2DF3D584C47C.md)
- 2025-11-30 to 2026-02-28 | total_assets | 64,698,463,000 United States dollar | superseded | [clm_0AB1BF04B5A2](/claim/clm_0AB1BF04B5A2.md)
- 2025-11-30 to 2026-02-28 | quarterly_operating_income | 2,873,698,000 United States dollar | superseded | [clm_5DDEE5279247](/claim/clm_5DDEE5279247.md)
- 2025-11-30 to 2026-02-28 | quarterly_net_income | 2,211,561,000 United States dollar | superseded | [clm_9AFF0D6FF3B6](/claim/clm_9AFF0D6FF3B6.md)
- 2025-11-30 to 2026-02-28 | quarterly_revenue | 18,742,125,000 United States dollar | superseded | [clm_AD416338D784](/claim/clm_AD416338D784.md)
- 2025-11-30 to 2026-02-28 | cash_and_equivalents | 9,649,405,000 United States dollar | superseded | [clm_E6093BCE9AAD](/claim/clm_E6093BCE9AAD.md)
- 2025-11-30 to 2026-02-28 | total_equity | 30,867,503,000 United States dollar | superseded | [clm_F0341295AF04](/claim/clm_F0341295AF04.md)
- 2025-12-01 | owned_by | The Vanguard Group | unverified | [clm_3EA23470ECEE](/claim/clm_3EA23470ECEE.md)
- 2025-12-01 | owned_by | BlackRock | unverified | [clm_5197C23F14D1](/claim/clm_5197C23F14D1.md)

## 2026

- 2026-02-28 to 2026-05-31 | quarterly_revenue | 18,044,066,000 United States dollar | superseded | [clm_2F2BE7D21780](/claim/clm_2F2BE7D21780.md)
- 2026-02-28 to 2026-05-31 | quarterly_operating_income | 2,493,547,000 United States dollar | superseded | [clm_3876C97EC21E](/claim/clm_3876C97EC21E.md)
- 2026-02-28 to 2026-05-31 | cash_and_equivalents | 9,399,183,000 United States dollar | superseded | [clm_6E0440CB250F](/claim/clm_6E0440CB250F.md)
- 2026-02-28 to 2026-05-31 | total_equity | 31,210,676,000 United States dollar | superseded | [clm_804AC1FAC0CB](/claim/clm_804AC1FAC0CB.md)
- 2026-02-28 to 2026-05-31 | total_assets | 67,064,216,000 United States dollar | superseded | [clm_8B8463350AAF](/claim/clm_8B8463350AAF.md)
- 2026-02-28 to 2026-05-31 | quarterly_net_income | 1,825,239,000 United States dollar | superseded | [clm_B9956A149DAC](/claim/clm_B9956A149DAC.md)
- 2026-05-31 to 2026-08-31 | cash_and_equivalents | 10,165,245,000 United States dollar | superseded | [clm_13A07BD69873](/claim/clm_13A07BD69873.md)
- 2026-05-31 | quarterly_revenue | 18,718,144,000 United States dollar | valid | [clm_26CE6A6E9A0F](/claim/clm_26CE6A6E9A0F.md)
- 2026-05-31 to 2026-08-31 | total_assets | 68,806,561,000 United States dollar | superseded | [clm_34B1C2DE40B5](/claim/clm_34B1C2DE40B5.md)
- 2026-05-31 | quarterly_net_income | 2,338,989,000 United States dollar | valid | [clm_767C6434AE94](/claim/clm_767C6434AE94.md)
- 2026-05-31 to 2026-08-31 | total_equity | 31,890,566,000 United States dollar | superseded | [clm_CB9ED271948E](/claim/clm_CB9ED271948E.md)
- 2026-05-31 | quarterly_operating_income | 3,175,298,000 United States dollar | valid | [clm_D8924F0F9834](/claim/clm_D8924F0F9834.md)
- 2026-08-31 | total_assets | 73,597,792,000 United States dollar | valid | [clm_0AF2F977A3E6](/claim/clm_0AF2F977A3E6.md)
- 2026-08-31 | operating_income | 11,405,960,000 United States dollar | valid | [clm_320CE722097A](/claim/clm_320CE722097A.md)
- 2026-08-31 | net_income | 8,367,056,000 United States dollar | valid | [clm_644144BDEBF0](/claim/clm_644144BDEBF0.md)
- 2026-08-31 | research_and_development | 1,011,258,000 United States dollar | valid | [clm_D201BCA6B9B2](/claim/clm_D201BCA6B9B2.md)
- 2026-08-31 | revenue | 74,183,445,000 United States dollar | valid | [clm_DFFE616D0986](/claim/clm_DFFE616D0986.md)
- 2026-08-31 | cash_and_equivalents | 12,831,471,000 United States dollar | valid | [clm_E1F6610D2A40](/claim/clm_E1F6610D2A40.md)
- 2026-08-31 | total_equity | 31,567,256,000 United States dollar | valid | [clm_F5F8C0561A33](/claim/clm_F5F8C0561A33.md)
- 2026-10-28 | market_cap | 145,550,000,000 United States dollar | unverified | [clm_782773C11F9F](/claim/clm_782773C11F9F.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.